Core One Labs is a publicly traded Canadian life sciences biotechnology research and development company focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments.
The Company’s shares are listed on the Canadian Securities Exchange (CSE), on OTCQB Markets (OTCQB) and on the Frankfurt Stock Exchange (FWB) under the following tickers:
CSE: “COOL”
OTCQB: “CLABF”
FWB: “LD6” (WKN: A3CSSU)